Mixed Dyslipidemia
📧 Sign up to get email alerts when something new happens for Mixed Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen [Phase 3]
Phase 3 trial assessing in-home use of evolocumab via prefilled syringe or autoinjector; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia [Phase 4]
Phase 4 trial evaluating the efficacy and safety of fluvastatin sodium extended-release 80 mg once daily in Chinese patients with primary hy…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)
The Niacin/laropiprant re-examination study (TREDAPTIVE) for hypercholesterolemia and mixed dyslipidemia was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133) [Phase 3]
Phase 3 trial evaluating MK-0524A (extended-release niacin/laropiprant) added to ongoing lipid-modifying therapy in patients with primary hy…
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia [Phase 4]
Phase 4 trial comparing pitavastatin 4 mg to pravastatin 40 mg in adults with primary hyperlipidemia or mixed dyslipidemia has completed and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of fluvastatin in children with heterozygous familial hypercholesterolemia; the study has c…
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia [Phase 3]
This Phase 3 safety-extension trial evaluates ABT-335 in combination with statin therapy for mixed dyslipidemia; results were posted in 2009…
-
CLINICAL_TRIALS trial_result · 2009-11-05Clinical Trial Update: Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood [Phase 3]
Phase 3 safety and efficacy study comparing ABT-335 coadministered with atorvastatin and ezetimibe versus atorvastatin with ezetimibe in sub…
-
CLINICAL_TRIALS trial_result · 2009-07-31Clinical Trial Update: Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) [Phase 3]
A Phase 3 study evaluating extended-release niacin with laropiprant for lipid management in adults with primary hypercholesterolemia or mixe…
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. [Phase 3]
A Phase 3 trial evaluating ABT-335 in combination with three different statins in subjects with mixed dyslipidemia, examining long-term safe…
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) [Phase 3]
This completed Phase 3 open-label trial evaluated lipid-lowering effects of Niacin ER combined with Simvastatin versus Atorvastatin in adult…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood [Phase 3]
A Phase 3 trial evaluated the safety and efficacy of ABT-335 in combination with atorvastatin in subjects with mixed dyslipidemia and corona…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood [Phase 3]
Phase 3 trial evaluating safety and efficacy of ABT-335 in combination with rosuvastatin in subjects with multiple abnormal lipid levels has…
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study [NA]
The DIACOR study evaluating diabetes and combined lipid therapy has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
A completed clinical trial comparing simvastatin plus Omacor to simvastatin plus placebo in subjects with mixed dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2006-06-28Clinical Trial Update: Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care [Phase 4]
Phase 4 efficacy trial comparing Extended-Release Niacin/Lovastatin to usual care in patients with lipid disorders. The study has completed.